Skip to main content

Advertisement

Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges

This series of articles investigates a broad range of legal, management, ethical, economic, and social issues associated with the translation and commercialization of regenerative medicine technologies and services. Articles published in this series were invited from delegates that attended Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges, held In Toronto, ON, November 5-7, 2014. The organizers would like to thank the Stem Cell Network, the Cancer Stem Cell Consortium, Genome Canada, Genome Quebec, Genome Alberta, the Ontario Genomics Institute, the Canadian Institutes for Health Research, and Alberta Innovates-Health Solutions for their generous support of both this event.

All articles have been independently prepared by the authors and have been subject to the standard peer review processes of the journals.

  1. Research article

    Challenges in the translation and commercialization of cell therapies

    Cell therapies are an emerging form of healthcare that offer significant potential to improve the practice of medicine and provide benefits to patients who currently have limited or no treatment options. Ideal...

    Brittany P. Dodson and Aaron D. Levine

    BMC Biotechnology 2015 15:70

    Published on: 7 August 2015

Advertisement